NM_133496.5:c.71G>A
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_133496.5(SLC30A7):c.71G>A(p.Gly24Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000297 in 1,614,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_133496.5 missense
Scores
Clinical Significance
Conservation
Publications
- Joubert syndromeInheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC30A7 | ENST00000357650.9 | c.71G>A | p.Gly24Asp | missense_variant | Exon 1 of 11 | 1 | NM_133496.5 | ENSP00000350278.4 | ||
SLC30A7 | ENST00000370112.8 | c.71G>A | p.Gly24Asp | missense_variant | Exon 1 of 12 | 1 | ENSP00000359130.4 | |||
SLC30A7 | ENST00000850622.1 | n.71G>A | non_coding_transcript_exon_variant | Exon 1 of 13 | ENSP00000520907.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152172Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000756 AC: 19AN: 251330 AF XY: 0.000110 show subpopulations
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461880Hom.: 0 Cov.: 31 AF XY: 0.0000426 AC XY: 31AN XY: 727238 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152172Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74330 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.71G>A (p.G24D) alteration is located in exon 1 (coding exon 1) of the SLC30A7 gene. This alteration results from a G to A substitution at nucleotide position 71, causing the glycine (G) at amino acid position 24 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at